Morningstar Retirement offers products designed to help individuals reach their retirement goals. Our products and services also enable industry players to differentiate their services, stay ...

From data feeds and research delivery to comprehensive platforms and advanced analytics, Morningstar Data+Analytics informs and empowers professional investors so they can create great products ...

Mutual fund investors have saved billions in fund fees over the past two decades. In 2022, the average expense ratio of all U.S. open-end mutual funds and exchange-traded funds was 0.37%, compared ...

Since the European Union's Sustainable Finance Disclosure Regulation came into force in March 2021, asset managers have been required to provide more information on the sustainability risks and ...

Will SFSNX outperform in future? Get our overall rating based on a fundamental assessment of the pillars below. On March 19, 2024, Schwab Asset Management announced that 12 of its exchange-traded ...

Nuveen announced on Jan. 22, 2024, that its TIAA-CREF funds will be renamed as Nuveen funds. The name change will go into effect on May 1, 2024. According to the announcement, some funds will also ...

Nuveen announced on Jan. 22, 2024, that its TIAA-CREF funds will be renamed as Nuveen funds. The name change will go into effect on May 1, 2024. According to the announcement, some funds will also ...

Will MDFOX outperform in future? Get our overall rating based on a fundamental assessment of the pillars below. A planned merger of BlackRock Large Cap Focus Growth and BlackRock Capital ...

On Feb. 1, Columbia Dividend Income formally named Andrew Wright as the third portfolio manager on the fund. Wright joined Columbia from Portolan Capital a year ago and began working with this ...

Will ANCFX outperform in future? Get our overall rating based on a fundamental assessment of the pillars below. Capital Group has announced that Brady Enright stepped down as lead principal ...

In the first quarter, AbbVie reported a 36% drop in Humira-related revenue, driving a 3.9% decline in revenue coming from its immunology portfolio. Despite this, its quarterly topline performance rose ...

However, based on Morningstar equity analysts’ earnings forecast for the full year, the new dividend rate represents just 12% ...